Leigh Ann Anderson

2 days ago | drugs.com | Leigh Ann Anderson

Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss? There’s no evidence that hair loss is a direct side effect of Ozempic, Wegovy, Mounjaro or Zepbound. Hair loss is more likely due to the stress of rapid weight loss on your body, which can lead to temporary shedding of hair over several months, a condition known as telogen effluvium.

1 month ago | drugs.com | Leigh Ann Anderson

Recently Approved Vanrafia Vanrafia (atrasentan) is an endothelin A receptor antagonist used for... Qfitlia Qfitlia (fitusiran) is an antithrombin-directed small interfering ribonucleic... Vykat XR Vykat XR (diazoxide choline) is an extended-release formulation of the...

May 28, 2024 | drugs.com | Leigh Ann Anderson

Can Gemtesa cause dementia? Cognitive decline, which may include dementia, memory loss and confusion, is not a known side effect for Gemtesa (vibegron) or the beta-3 agonist class as a whole. In addition, a study found the use of anticholinergic medications among patients with overactive bladder (OAB) was associated with an increased risk of new-onset dementia compared to beta-3 agonist users.

Jan 16, 2024 | drugs.com | Leigh Ann Anderson

There are no specific foods to avoid, but if you are being treated for type 2 diabetes you should avoid regular consumption of foods high in fat, sugar and calories. Rybelsus works best if you combine it with a healthy diet and exercise plan as recommended by your healthcare provider. Although you don't have to avoid specific foods with Rybelsus, but you must take this medicine on an empty stomach when you first wake up with a sip of plain water (4 ounces or less).

Aug 24, 2023 | drugs.com | Leigh Ann Anderson

Ingrezza (valbenazine) capsules and Ingrezza Sprinkle capsules are approved for the treatment of adults with tardive dyskinesia and for adults with chorea associated with Huntington's disease (HD), two types of involuntary movement disorders. Ingrezza is a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor. Tardive dyskinesia (TD) is characterized by abnormal and repetitive movements of the trunk, extremities or face.